May 10, 2023

084 - Drug Discovery, Candidate Selection, Pre-Clinical Development, IND Submissions, Administration Route Selection, TPP and Toxicology with Marta New

084 - Drug Discovery, Candidate Selection, Pre-Clinical Development, IND Submissions, Administration Route Selection, TPP and Toxicology with Marta New
The player is loading ...
084 - Drug Discovery, Candidate Selection, Pre-Clinical Development, IND Submissions, Administration Route Selection, TPP and Toxicology with Marta New
084 - Drug Discovery, Candidate Selection, Pre-Clinical Development, IND Submissions, Administration Route Selection, TPP and Toxicology with Marta New
Apple Podcasts podcast player badge
Spotify podcast player badge
Castro podcast player badge
RSS Feed podcast player badge
Apple Podcasts podcast player icon Spotify podcast player icon Castro podcast player icon RSS Feed podcast player icon

On this episode, I was joined by Marta New, the CEO of Radyus Research. Dr. New discusses:

  • (0:00) Intro
  • (1:37) Pre-Clinical Planning
  • (7:15) What's the purpose of an IND?
  • (14:10) Administration Route Selection
  • (19:00) Candidate Selection and Animal Models
  • (30:10) Pre-IND Meeting
  • (44:00) IND Submissions and Approval

Marta New PhD MBA is the CEO of Radyus Research. She is an experienced drug developer with a background in early-stage venture capital, considerable pharma R&D, and university technology transfer.